BioCentury | Sep 29, 2020
Financial News

Sept. 28 Quick Takes: Biogen gains $1.4B on aducanumab update; plus Zai, XtalPi, InventisBio, Galecto, Innovent, Galapagos-Gilead, Biocytogen and ACT Accelerator

...Foundation —with Abbott Laboratories (NYSE:ABT) and SD Biosensor Inc....
BioCentury | Feb 27, 2012
Company News

SD Biosensor, Shanghai Fosun Pharmaceutical deal

...diagnostics, including the LipidoCare Lipid Analyzer to measure HDL cholesterol, LDL cholesterol and glucose levels. SD Biosensor Inc....
Items per page:
1 - 2 of 2
BioCentury | Sep 29, 2020
Financial News

Sept. 28 Quick Takes: Biogen gains $1.4B on aducanumab update; plus Zai, XtalPi, InventisBio, Galecto, Innovent, Galapagos-Gilead, Biocytogen and ACT Accelerator

...Foundation —with Abbott Laboratories (NYSE:ABT) and SD Biosensor Inc....
BioCentury | Feb 27, 2012
Company News

SD Biosensor, Shanghai Fosun Pharmaceutical deal

...diagnostics, including the LipidoCare Lipid Analyzer to measure HDL cholesterol, LDL cholesterol and glucose levels. SD Biosensor Inc....
Items per page:
1 - 2 of 2